Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance.

Kinchen VJ, Massaccesi G, Flyak AI, Mankowski MC, Colbert MD, Osburn WO, Ray SC, Cox AL, Crowe JE Jr, Bailey JR.

J Clin Invest. 2019 Aug 13;130. pii: 130720. doi: 10.1172/JCI130720.

2.

Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.

Colbert MD, Flyak AI, Ogega CO, Kinchen VJ, Massaccesi G, Hernandez M, Davidson E, Doranz BJ, Cox AL, Crowe JE Jr, Bailey JR.

J Virol. 2019 Jun 28;93(14). pii: e02070-18. doi: 10.1128/JVI.02070-18. Print 2019 Jul 15.

PMID:
31068427
3.

HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.

Flyak AI, Ruiz S, Colbert MD, Luong T, Crowe JE Jr, Bailey JR, Bjorkman PJ.

Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3. doi: 10.1016/j.chom.2018.10.009.

PMID:
30439340

Supplemental Content

Loading ...
Support Center